Prime Movers Lab leads $15m round for Elevian

Massachusetts-based Elevian, a developer of medicines focused on multiple age-related diseases, has secured $15 million in financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this